Satoru I. Takahashi
Distinguished in Multicentric Carpotarsal Osteolysis Syndrome

Satoru I. Takahashi

Tsukuba, JP 
Distinguished in Multicentric Carpotarsal Osteolysis Syndrome
Tsukuba, JP 
OverviewLocationsClinical Research

Overview

Satoru Takahashi practices in Tsukuba, Japan. Mr. Takahashi is rated as a Distinguished expert by MediFind in the treatment of Multicentric Carpotarsal Osteolysis Syndrome. His top areas of expertise are Prostate Cancer, Multicentric Carpotarsal Osteolysis Syndrome, Frequent or Urgent Urination, Endoscopy, and Thrombectomy.

His clinical research consists of co-authoring 889 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Multicentric Carpotarsal Osteolysis Syndrome.

Gender
Male

Locations

Tsukuba, Japan
Other Locations
Tokyo, Japan
Osaka, Japan
Nagoya, Japan
Bunkyo, Japan
Takatsuki, Japan
Shimotsuke, Japan
Hamamatsu, Japan
Kobe, Japan
Tochigi, Japan
Itabashi, Japan
Itabashi, Japan
Yushima, 1138519, Japan
Chiyoda, Japan
Kyoto, 6068502, Japan
Hongo, 1138656, Japan
Japan
Hachioji, Japan
Sendai, Japan
Okazaki, Japan
Kasuga, 1128551, Japan
Chiyoda, Japan
Fuchu, 1838509, Japan
Tennodai, Japan
Soka, Japan
Nishinomiya-hama, Japan
Chiba, Japan
Tohoku, Japan
Ikenohata, 1108782, Japan
Takamatsu, Japan
Morohongo, 3500495, Japan
Kashiwa, Japan
Chuo, Japan
Funabashi, Japan
Saitama, Japan
Chuo, 6500017, Japan
Amagasaki, 6610976, Japan
Matsumoto, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

887 Total Publications

Lysophosphatidic acid-mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development.
Lysophosphatidic acid-mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development.
Journal: The Journal of clinical investigation
Published: January 13, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takahashi's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 161 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile